- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- Fact Check
- Bone Health Fact Check
- Brain Health Fact Check
- Cancer Related Fact Check
- Child Care Fact Check
- Dental and oral health fact check
- Diabetes and metabolic health fact check
- Diet and Nutrition Fact Check
- Eye and ENT Care Fact Check
- Fitness fact check
- Gut health fact check
- Heart health fact check
- Kidney health fact check
- Medical education fact check
- Men's health fact check
- Respiratory fact check
- Skin and hair care fact check
- Vaccine and Immunization fact check
- Women's health fact check
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
Six in Ten with Type 2 Diabetes Have Fatty Liver: Study Finds - Video
Overview
A new study published in the Journal of Internal Medicine reveals that nearly 60% of individuals with type 2 diabetes also have fatty liver disease, although only a small fraction show signs of more advanced liver damage.
Fatty liver disease, or metabolic dysfunction-associated fatty liver disease (MASLD), is closely tied to metabolic syndrome - a cluster of conditions that disrupt normal metabolism and increase the risk of type 2 diabetes, cardiovascular disease, and liver complications.
To obtain representative data, the researchers studied more than 300 individuals with type 2 diabetes who were undergoing routine primary healthcare diabetes checks. Using MRI scans, they found that 59% had MASLD. Liver stiffness was also assessed using ultrasound-based technology, which showed that around 7% of participants had signs of early-stage cirrhosis, less than reported in studies conducted at specialist clinics.
Obesity emerged as a key factor in disease progression. In this subgroup, 13% showed early liver scarring, compared to just 2% among those without obesity.
“It’s of great importance to find the few individuals who are at high risk of serious liver disease, because we can do a lot of good for those patients. But it’s like looking for a needle in a haystack,” said Mattias Ekstedt, senior associate professor at Linköping University and consultant in hepatology. “Hopefully, our data will help to find the high-risk individuals among all patients.”
Fortunately, fatty liver isn’t irreversible. Weight loss has been shown to significantly reduce liver fat. The study will follow participants over five years to better identify who is most at risk and to guide future screening efforts.
Reference: Balkhed W, Bergram M, Iredahl F, Holmberg M, Edin C, Carlhäll C-J, et al. Evaluating the prevalence and severity of metabolic dysfunction-associated steatotic liver disease in patients with type 2 diabetes mellitus in primary care. J Intern Med. 2025;e20103.
Speakers
Dr. Bhumika Maikhuri
BDS, MDS